- Zeps, N. Iacopetta, B.J. Schofield, L. George, J.M. & Goldblatt, J. (2007) 'Waiver of individual consent in research: When do potential benefits to the community outweigh private rights?', Medical Journal of Australia 186(2): 88-90
- Craig C. Whiteford, Sven Bilke, Braden T. Greer, Qingrong Chen, Till A. Braunschweig, Nicola Cenacchi, Jun S. Wei, Malcom A. Smith, Peter Houghton, Christopher Morton, C. Patrick Reynolds, Richard Lock, Richard Gorlick, Chand Khanna, Carol J. Thiele, Mikiko Takikita, Daniel Catchpoole, Stephen M. Hewitt and Javed Khan. “Credentialing preclinical pediatric xenograft models using gene expression and tissue microarray analysis”. Cancer Research 2007;67 (1). January, 2007
- Greenman C, Stephens P, Smith R, Dalgliesh G, Hunter C, Bignell G, Davies H, Teague J, Butler A, Stevens C, Edkins S, O’Meara S, Vastrik I, Schmidt E, Avis T, Barthorpe S, Bhamra G, Buck G, Choudhury B, Clements J, Cole J, Dicks E, Forbes S, Gray K, Halliday K, Harrison R, Hills K, Hinton J, Jenkinson A, Jones D, Menzies A, Mironenko T, Perry J, Raine K, Richardson D, Shepherd R, Small A, Tofts C, Varian J, Webb T, West S, Widaa S, Yates A, Cahill DP, Louis DN, Goldstraw P, Nicholson AG, Brasseur F, Looijenga L, Weber BL, Chiew Y-E, deFazio A, Greaves MF, Green AR, Birney E, Easton DF, Chenevix-Trench G, Khoo SK, Tan M-H, Teh BT, Yuen ST, Leung SY, Wooster R, Futreal PA, Stratton MR. Patterns of somatic mutation in human cancer genomes. Nature 446:153-158, 2007
- Creaney J, van Bruggen I, Hof M, Segal A, Musk AW, de Klerk N, Horick N, Skates SJ, Robinson BW. Combined CA125 and Mesothelin Levels for the Diagnosis of Malignant Mesothelioma. Chest 2007; 132(4): 1239-1246
- Creaney J, Yeoman D, Naumoff LK, Hof M, Segal A, Musk AW, De Klerk N, Horick N, Skates SJ & Robinson BWS. Soluble mesothelin in effusions: a useful tool for the diagnosis of malignant mesothelioma. Thorax 2007; 62(7): 569-576
- Catchpoole D.R., Lail A., Guo D., Chen Q., Khan J. Gene expression profiles that segregate patients with childhood acute lymphoblastic leukaemia: An independent validation study identifies that endoglin associates with patient outcome. Leukaemia Research 2007; 31(12): 1741-1747
Categories: